ModerateSulfonamide-trimethoprim combination×Atypical antipsychotic – dopamine and serotonin receptor antagonist
Updated · Methodology
Mechanism
Risperidone is metabolised in the liver by CYP2D6 to 9-hydroxyrisperidone, which has similar activity (Risperdal SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). The trimethoprim component of co-trimoxazole is excreted mainly by the kidneys, about half of the dose unchanged within 24 hours (Septrin SmPC, AEMPS, section 5.2). The documents describe no pharmacokinetic interaction. The link is the QT interval. The risperidone SmPC calls for caution with drugs known to prolong the QT interval (AEMPS, sections 4.4 and 4.5), and the US co-trimoxazole label lists QT prolongation resulting in ventricular tachycardia and torsade de pointes among its adverse reactions (Bactrim prescribing information, US Food and Drug Administration, FDA).
Symptoms
QT prolongation with co-trimoxazole can result in ventricular tachycardia and torsade de pointes (Bactrim prescribing information, US Food and Drug Administration, FDA). QT prolongation has been reported very rarely with risperidone after marketing, and the risk of arrhythmia is higher with heart disease, bradycardia, low potassium or magnesium, and other QT-prolonging drugs (Risperdal SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). Co-trimoxazole very commonly raises potassium and can cause severe skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis (Septrin SmPC, AEMPS, sections 4.4 and 4.8).
Management
The combination can be used with caution: the risperidone SmPC calls for it with drugs known to prolong the QT interval (Risperdal SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.5), and co-trimoxazole prolongs QT according to its US label (Bactrim prescribing information, US Food and Drug Administration, FDA). Particular caution is needed in people with cardiovascular disease, a family history of QT prolongation, bradycardia, or low potassium or magnesium (Risperdal SmPC, AEMPS, section 4.4). During co-trimoxazole treatment, the person is closely monitored for skin reactions and told about their signs (Septrin SmPC, AEMPS, section 4.4). The documents call for no dose changes.
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Bactrim (sulfamethoxazole and trimethoprim) prescribing information (2013)– ; DailyMed setid f59d0c04-9c66-4d53-a0e1-cb55570deb62
- AEMPS: Ficha técnica: Risperidona (nº registro 60336), sección 4.5 (2025)– AEMPS, CIMA, nº registro 60336 (Risperdal 1 mg comprimidos recubiertos con película, Janssen-Cilag), revisión 05/2025, secciones 4.4, 4.5, 4.9 y 5.2
- AEMPS: Ficha técnica: Sulfametoxazol/trimetoprima, Septrin Forte 160 mg/800 mg (nº registro 58501), sección 4.5 (2026)– AEMPS, CIMA, nº registro 58501 (Septrin Forte 160 mg/800 mg comprimidos, Teofarma; ficha común con Septrin Pediátrico, nº 48669 y 48671), revisión 07/2026, sección 4.5